Clinical efficacy of trimebutine maleate combined with Morita therapy in treatment of patients with irritable bowel syndrome
- VernacularTitle:马来酸曲美布汀联合门诊森田疗法治疗肠易激综合征的临床研究
- Author:
Jun LI
;
Qiaoling XU
;
Weiguo CHEN
;
- Publication Type:Journal Article
- Keywords:
trimebutine maleate;
Morita therapy;
irritable bowel syndrome (IBS);
self-rating anxiety scale (SAS);
self-rating depression scale (SDS);
bio-psycho-social medical model
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2000;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To investigate the clinical efficacy of trimebutine maleate combined with Morita therapy in the treatment of patients with irritable bowel syndrome (IBS). METHODS: 108 patients were randomly assigned to two groups. Trimebutine maleate group (n=54) was given trimebutine maleate 200 mg, po, tid, combined with Mortia therapy. The patients were analyzed by self rating anxiety scale (SAS) and self rating depression scale (SDS) before and after the treatment. Control group (n=54) was only given trimebutine maleate 200 mg, po, tid. The course was 4 weeks. RESULTS: The total efficacy rates were 87.04 % and 72.22 % in trimebutine maleate group and in control group, respectively. The therapeutic effects in trimebutine maleate group were better than those in the control group (P
